Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of 4-methylpyrazole on Acetaminophen Metabolism
NCT03878693Phase 1Completed
- Sponsor
- University of Arizona
- Start
- Jul 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fomepizole in acetaminophen toxicity (2 arms), sponsored by University of Arizona. Primary endpoint: Oxidative metabolism of Acetaminophen at 24 hours. Started Jul 2018; status: completed.
02
Drugs
fomepizole
03
Conditions
acetaminophen toxicity
Beyond the preview
Go deeper on NCT03878693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03878693.